To test or not to test? Revisiting the value of baseline screening and monitoring tests among biologic treatments for psoriasis using an evidence-based assessment
Surgical excision versus topical 5% 5-fluorouracil and photodynamic therapy in the treatment of Bowen's disease: Long-term results of a multicenter randomized controlled trial
A new perspective on the treatment and management of atypical nevi: A blinded retrospective analysis of atypical nevi utilizing line-field confocal optical coherence tomography
Cutaneous adverse events associated with mitogen activated protein kinase inhibitors for the treatment of vascular anomalies: A dual-center retrospective study
Biologic therapy and risk of paradoxical eczema in psoriasis: A propensity-matched cohort analysis of tumor necrosis factor-α and interleukin 17 inhibitors using TriNetX
Dupilumab treatment improves health-related quality of life in patients with moderate-to-severe atopic dermatitis primarily affecting the hands (atopic hand eczema): Results from a randomized placebo-controlled trial
Patient triage for new appointments in medical dermatology may help decrease long waits for urgent and high-risk conditions: A multivariate retrospective analysis of factors associated with appointment lead times
Cutaneous lupus damage is negatively predicted by disease subtype and systemic involvement and is associated with worse outcomes in body image: A prospective cohort study
Ochre fluorescence under ultraviolet-induced fluorescence dermatoscopy is a strong clue to melanoma: Results of an international retrospective cross-sectional study
Impact of state-level indoor tanning legislation on adolescent behavior and ultraviolet radiation exposure in the United States: A policy-based narrative review
Methodological considerations of GPT-4 Vision in dermoscopic image analysis: comment on “Comparative assessment of GPT-4 Vision in dermoscopic image analysis�
Commentary on “Evaluating the performance of ChatGPT on dermatology board-style exams: A meta-analysis of text-based and image-based question accuracy� by Chen et al
Comment on ‘Efficacy, safety, and B-cell depletion capacity of 3 rituximab dosing regimens in the treatment of moderate-to-severe pemphigus vulgaris and pemphigus foliaceus: A 52-week clinical trial’
Response to Xue et al, “Comment on ‘Efficacy, safety, and B-cell depletion capacity of 3 rituximab dosing regimens in the treatment of moderate-to-severe pemphigus vulgaris and pemphigus foliaceus: A 52-week clinical trial’�